Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
Toby Pillinger, Enrico D’Ambrosio, Robert A. McCutcheon, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 6, pp. 776-794
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
Toby Pillinger, Robert A. McCutcheon, Luke Vano, et al.
The Lancet Psychiatry (2019) Vol. 7, Iss. 1, pp. 64-77
Open Access | Times Cited: 711
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
Christoph U. Correll, Marco Solmi, Giovanni Croatto, et al.
World Psychiatry (2022) Vol. 21, Iss. 2, pp. 248-271
Open Access | Times Cited: 368
Treatment resistance in psychiatry: state of the art and new directions
Oliver Howes, Michael E. Thase, Toby Pillinger
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 58-72
Open Access | Times Cited: 242
Cytokine Alterations in Schizophrenia: An Updated Review
Sara Momtazmanesh, Ameneh Zare-Shahabadi, Nima Rezaei
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 218
Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia
Błażej Misiak, Edyta Pawlak, Krzysztof P. Rembacz, et al.
Journal of Psychiatric Research (2024) Vol. 171, pp. 152-160
Closed Access | Times Cited: 25
Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis
Sean Halstead, Chester Cao, Grímur Høgnason Mohr, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 6, pp. 431-442
Closed Access | Times Cited: 17
A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
Toby Pillinger, Emanuele F. Osimo, Stefan Brugger, et al.
Schizophrenia Bulletin (2018) Vol. 45, Iss. 5, pp. 1120-1133
Open Access | Times Cited: 152
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
Nuray Çakici, Arjen L. Sutterland, Brenda W.J.H. Penninx, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 547-558
Open Access | Times Cited: 132
Is It Possible to Predict the Future in First-Episode Psychosis?
Jaana Suvisaari, Outi Mantere, Jaakko Keinänen, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 83
Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
Błażej Misiak, Francesco Bartoli, Giuseppe Carrà, et al.
Psychoneuroendocrinology (2021) Vol. 127, pp. 105200-105200
Open Access | Times Cited: 73
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 58
New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
Maria Lobo, Thomas Whitehurst, Stephen Kaar, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 324-361
Open Access | Times Cited: 57
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6460-6501
Open Access | Times Cited: 54
The Traumatizing Impact of Racism in Canadians of Colour
Monnica T. Williams, Anjalika Khanna Roy, M. Myriah MacIntyre, et al.
Current Trauma Reports (2022) Vol. 8, Iss. 2, pp. 17-34
Open Access | Times Cited: 47
White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis
Inês Figueiredo, Faith Borgan, Ofer Pasternak, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1413-1420
Open Access | Times Cited: 45
Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study
Toby Pillinger, Emanuele F. Osimo, Antonio de Marvao, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 2, pp. 98-107
Open Access | Times Cited: 37
Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: A systematic review and meta-analysis of 69 studies with 5710 participants
Nicola Warren, Cullen O’Gorman, Isabelle Horgan, et al.
Schizophrenia Research (2024) Vol. 266, pp. 24-31
Open Access | Times Cited: 14
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology
Robert A. McCutcheon, Lilian Weber, Matthew M. Nour, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 554-565
Closed Access | Times Cited: 10
The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol
Calogero Longhitano, Sabine Finlay, Isabella Peachey, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 10
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
Nina Dedic, Lien Wang, Éva Hajós‐Korcsok, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101883-101883
Open Access | Times Cited: 8
Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2834-2848
Open Access | Times Cited: 8
Skin advanced glycation end products, indicating cumulative oxidative stress, associated with schizophrenia but not with psychosis-like experiences
J M Hagen, A Cornelissen, Rada R Veeneman, et al.
Schizophrenia Research (2025) Vol. 276, pp. 237-242
Open Access | Times Cited: 1
Choroid Plexus Enlargement and Allostatic Load in Schizophrenia
Yanfang Zhou, Junchao Huang, Ping Zhang, et al.
Schizophrenia Bulletin (2019) Vol. 46, Iss. 3, pp. 722-731
Open Access | Times Cited: 68
Neurococognitive and neuroimaging correlates of obesity and components of metabolic syndrome in bipolar disorder: a systematic review
Emre Bora, Roger S. McIntyre, Ayşegül Özerdem
Psychological Medicine (2018) Vol. 49, Iss. 5, pp. 738-749
Closed Access | Times Cited: 66
Intracellular calcium dysregulation in autism spectrum disorder: An analysis of converging organelle signaling pathways
Rachel Nguyen, Yuliya V. Medvedeva, Tejasvi E Ayyagari, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2018) Vol. 1865, Iss. 11, pp. 1718-1732
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top